These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25782198)

  • 21. [Antihypertensive therapy in chronic kidney disease: what targets and how to reach them].
    Bock A
    Ther Umsch; 2018; 75(6):365-369. PubMed ID: 30880625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent update in the management of hypertension.
    Lim S
    Acta Med Indones; 2007; 39(4):186-91. PubMed ID: 18380058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salt, the renin-angiotensin-aldosterone system and resistant hypertension.
    Shimosawa T
    Hypertens Res; 2013 Aug; 36(8):657-60. PubMed ID: 23912973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of Hypertension in Patients with Chronic Kidney Disease in Asia.
    Huang QF; Hoshide S; Cheng HM; Park S; Park CG; Chen CH; Kario K; Wang JG;
    Curr Hypertens Rev; 2016; 12(3):181-185. PubMed ID: 27875953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic Issues in treating hypertension in CKD.
    Sica DA
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):42-7. PubMed ID: 21224029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypertension complicated with chronic kidney disease].
    Koizumi K; Ito S
    Nihon Rinsho; 2011 Nov; 69(11):2015-9. PubMed ID: 22111323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal protection with angiotensin receptor blockers: where do we stand.
    Schmieder RE; Ruilope LM; Barnett AH
    J Nephrol; 2011; 24(5):569-80. PubMed ID: 21404225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of sodium restriction and diuretic therapy for "resistant" hypertension in chronic kidney disease.
    Sinnakirouchenan R; Kotchen TA
    Semin Nephrol; 2014; 34(5):514-9. PubMed ID: 25416660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome?
    Vemulapalli S; Tyson CC; Svetkey LP
    Adv Chronic Kidney Dis; 2014 Nov; 21(6):489-99. PubMed ID: 25443574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which antihypertensive drugs are the most nephroprotective and why?
    Cravedi P; Ruggenenti P; Remuzzi G
    Expert Opin Pharmacother; 2010 Nov; 11(16):2651-63. PubMed ID: 20977400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
    Hirsch S
    Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypertension and renal disease].
    Kamper AL; Pedersen EB; Strandgaard S
    Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand?
    Chen SS; Seliger SL; Fried LF
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):449-55. PubMed ID: 25014549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypertension with chronic kidney disease: anti-hypertensive therapy recommended for the management of hypertension with CKD in JSN-CKD GL 2013 and JSH2014].
    Tamura K; Yutoh J; Matsushita K; Sakai M; Oshikawa J
    Nihon Rinsho; 2015 Nov; 73(11):1876-84. PubMed ID: 26619662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supratherapeutic doses of angiotensin receptor blockers to decrease proteinuria in patients with chronic kidney disease.
    Palmer BF
    Am J Nephrol; 2008; 28(3):381-90. PubMed ID: 18063856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic approaches in lowering albuminuria: travels along the renin-angiotensin-aldosterone-system pathway.
    Heerspink HJ
    Adv Chronic Kidney Dis; 2011 Jul; 18(4):290-9. PubMed ID: 21782135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood-pressure control and delay in progression of kidney disease in children.
    Ingelfinger JR
    N Engl J Med; 2009 Oct; 361(17):1701-3. PubMed ID: 19846857
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical role of direct renin inhibition in hypertension.
    Taylor AA; Pool JL
    Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.